https://www.selleckchem.com/pr....oducts/tacrine-hcl.h
Prospective validation studies are needed to advance the integration of proteomic analysis into precision oncology. Hypertension (HTN) and chronic kidney disease (CKD) are recognized as silent killers because they are asymptomatic conditions that contribute to the burden of multiple comorbidities. The achievement of a blood pressure (BP) goal can dramatically reduce the risks of CKD. In this study, we aimed to assess the effectiveness of pharmacist intervention on BP control in patients with CKD and evaluate the usefulness of home-b
Aimer
Commentaire
Partagez
